Transdermal fentanyl system plusimketorolac for the treatment of postoperative pain
β Scribed by Douglas J. Reinhart; Michael E. Goldberg; Jonathan V. Roth; Rita Dua; Igal Nevo; Kevin W. Klein; Marc Torjman; Denis Vekeman
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- French
- Weight
- 677 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1496-8975
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Transdermal fentanyl 75 micrograms/h (Fentanyl-TTS) was compared with placebo in a randomized double-blind study in the early postoperative period, using 50 patients recovering from major urological operations. Analgesic efficacy was individually titrated with intravenous fentanyl by means of a PCA
## Abstract ## BACKGROUND The delayed effects (12β16 hours) of transdermal fentanyl make dose titration difficult during acute exacerbations of cancer pain. Patients at the authors' institution routinely are switched from transdermal to intravenous (IV) fentanyl using a 1:1 (transdermal:IV) conver